Annual EBITDA
-$4.52 M
+$16.10 K+0.36%
31 October 2023
Summary:
Clearmind Medicine annual earnings before interest, taxes, depreciation & amortization is currently -$4.52 million, with the most recent change of +$16.10 thousand (+0.36%) on 31 October 2023. During the last 3 years, it has fallen by -$2.34 million (-107.96%). CMND annual EBITDA is now -5545.50% below its all-time high of -$80.00 thousand, reached on 01 October 2019.CMND EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.46 M
-$168.30 K-13.07%
31 July 2024
Summary:
Clearmind Medicine quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.46 million, with the most recent change of -$168.30 thousand (-13.07%) on 31 July 2024. Over the past year, it has dropped by -$1.49 million (-4382.65%). CMND quarterly EBITDA is now -4382.65% below its all-time high of $34.00 thousand, reached on 31 October 2023.CMND Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$4.09 M
-$371.10 K-9.99%
31 July 2024
Summary:
Clearmind Medicine TTM earnings before interest, taxes, depreciation & amortization is currently -$4.09 million, with the most recent change of -$371.10 thousand (-9.99%) on 31 July 2024. Over the past year, it has increased by +$419.20 thousand (+9.31%). CMND TTM EBITDA is now -78463.46% below its all-time high of -$5200.00, reached on 01 October 2017.CMND TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMND EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -4382.6% | +9.3% |
| 3 y3 years | -108.0% | -35.6% | -88.0% |
| 5 y5 years | -5545.5% | -7604.2% | -5045.2% |
CMND EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -108.0% | +0.4% | -4382.6% | +19.6% | -88.0% | +24.6% |
| 5 y | 5 years | -5545.5% | +0.4% | -4382.6% | +19.6% | -5045.2% | +24.6% |
| alltime | all time | -5545.5% | +0.4% | -4382.6% | +19.6% | <-9999.0% | +24.6% |
Clearmind Medicine EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| July 2024 | - | -$1.46 M(+13.1%) | -$4.09 M(+10.0%) |
| Apr 2024 | - | -$1.29 M(-6.4%) | -$3.71 M(-8.7%) |
| Jan 2024 | - | -$1.38 M(-4145.3%) | -$4.07 M(-9.7%) |
| Oct 2023 | -$4.52 M(-0.4%) | $34.00 K(-103.1%) | -$4.50 M(-13.1%) |
| July 2023 | - | -$1.08 M(-33.9%) | -$5.18 M(+1.5%) |
| Apr 2023 | - | -$1.64 M(-9.3%) | -$5.10 M(-1.4%) |
| Jan 2023 | - | -$1.81 M(+181.7%) | -$5.18 M(+3.8%) |
| Oct 2022 | -$4.53 M(+108.7%) | -$642.90 K(-36.2%) | -$4.99 M(-7.9%) |
| July 2022 | - | -$1.01 M(-41.2%) | -$5.42 M(+2.7%) |
| Apr 2022 | - | -$1.72 M(+5.6%) | -$5.28 M(+42.0%) |
| Jan 2022 | - | -$1.62 M(+51.2%) | -$3.72 M(+71.2%) |
| Oct 2021 | -$2.17 M | - | - |
| Oct 2021 | - | -$1.07 M(+23.8%) | -$2.17 M(+68.3%) |
| July 2021 | - | -$867.70 K(+464.2%) | -$1.29 M(+171.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Apr 2021 | - | -$153.80 K(+99.5%) | -$476.30 K(+29.8%) |
| Jan 2021 | - | -$77.10 K(-59.9%) | -$367.00 K(+18.9%) |
| Oct 2020 | -$309.90 K(+287.4%) | -$192.10 K(+260.4%) | -$308.70 K(+127.8%) |
| July 2020 | - | -$53.30 K(+19.8%) | -$135.50 K(+37.3%) |
| Apr 2020 | - | -$44.50 K(+136.7%) | -$98.70 K(+21.4%) |
| Jan 2020 | - | -$18.80 K(-0.5%) | -$81.30 K(+2.4%) |
| Oct 2019 | -$80.00 K(-58.8%) | -$18.90 K(+14.5%) | -$79.40 K(-62.8%) |
| July 2019 | - | -$16.50 K(-39.1%) | -$213.30 K(+0.8%) |
| Apr 2019 | - | -$27.10 K(+60.4%) | -$211.60 K(+12.3%) |
| Jan 2019 | - | -$16.90 K(-88.9%) | -$188.40 K(-3.6%) |
| Oct 2018 | -$194.00 K | -$152.80 K(+932.4%) | -$195.40 K(+308.8%) |
| July 2018 | - | -$14.80 K(+279.5%) | -$47.80 K(+44.8%) |
| Apr 2018 | - | -$3900.00(-83.7%) | -$33.00 K(+13.4%) |
| Jan 2018 | - | -$23.90 K(+359.6%) | -$29.10 K(+459.6%) |
| Oct 2017 | - | -$5200.00 | -$5200.00 |
FAQ
- What is Clearmind Medicine annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Clearmind Medicine?
- What is Clearmind Medicine quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Clearmind Medicine?
- What is Clearmind Medicine quarterly EBITDA year-on-year change?
- What is Clearmind Medicine TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Clearmind Medicine?
- What is Clearmind Medicine TTM EBITDA year-on-year change?
What is Clearmind Medicine annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CMND is -$4.52 M
What is the all time high annual EBITDA for Clearmind Medicine?
Clearmind Medicine all-time high annual earnings before interest, taxes, depreciation & amortization is -$80.00 K
What is Clearmind Medicine quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CMND is -$1.46 M
What is the all time high quarterly EBITDA for Clearmind Medicine?
Clearmind Medicine all-time high quarterly earnings before interest, taxes, depreciation & amortization is $34.00 K
What is Clearmind Medicine quarterly EBITDA year-on-year change?
Over the past year, CMND quarterly earnings before interest, taxes, depreciation & amortization has changed by -$1.49 M (-4382.65%)
What is Clearmind Medicine TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CMND is -$4.09 M
What is the all time high TTM EBITDA for Clearmind Medicine?
Clearmind Medicine all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5200.00
What is Clearmind Medicine TTM EBITDA year-on-year change?
Over the past year, CMND TTM earnings before interest, taxes, depreciation & amortization has changed by +$419.20 K (+9.31%)